2024-02-25 11:41:00 ET
Summary
- Today, we circle back on diagnostic concern Adaptive Biotechnologies Corporation, which recently posted its fourth quarter results.
- The company develops immune medicine platforms for the diagnosis and treatment of diseases, with its core growth driver being a product called clonoSEQ.
- A post earnings assessment around Adaptive Biotechnologies follows in the paragraphs below.
Those who cannot change their minds cannot change anything .” ? George Bernard Shaw
Read the full article on Seeking Alpha
For further details see:
Adaptive Biotechnologies: A Post Earnings Assessment